MARIAN DEHLINGER: Open Payments
NPI 1720104565 · SUMTER, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$375 in 17 payments from 6 companies in 2025. Trend: 2023 $152 · 2024 $337 · 2025 $375
Food & beverage: $375
| Company | Payments | Amount |
|---|---|---|
| Neurocrine BioSciences, Inc. | 6 | $146 |
| Alkermes, Inc. | 4 | $108 |
| Teva Pharmaceuticals USA, Inc. | 4 | $64 |
| ABBVIE INC. | 1 | $23 |
| E.R. Squibb & Sons, L.L.C. | 1 | $17 |
| Janssen Pharmaceuticals, Inc | 1 | $17 |
Products named: INGREZZA, UZEDY, LYBALVI, ARISTADA, COBENFY, INVEGA SUSTENNA.
Industry payments across SC — which companies pay providers there.
